Sr Market Access Manager – Switzerland & Austria

Position Overview

The Sr Market Access Manager CH & AT is responsible for developing strategically targeted payer engagement, relationship and account management at the country level for improved access and procurement of the Omnipod Insulin Management System. This includes implementing access strategies that establish pricing and value for successful patient access to the Omnipod system.

Efforts of this individual should focus on ensuring health care providers and patients have unimpeded access to our products and services by educating key stakeholders and influencing their medical policy decisions, their perceptions of the value Insulet provides them and their patients, and our competitive position relative to alternatives. The Sr Market Access Manager is expected to earn the support of his / her customers as a trusted business advisor. Success is reflected by the key stakeholders accepting and implementing versions of the Market Access recommendations. The Sr Market Access Manager will have a deep understanding of important territory-related issues, have broad knowledge of the evolving healthcare landscape, and develop detailed strategic plans which align with the long and short-term goals of the organization.

Responsibilities

Stakeholder Engagement & Policy Influence

• Establish and maintain relationships with key stakeholders in national healthcare systems.
• Identify policy priorities and share insights with leadership.
• Educate stakeholders to influence medical policy decisions and improve access.

Value & Pricing Strategy

Cross-functional Collaboration

Operational Execution & Reporting

Minimum Requirements

Education and Experience

Skills / Competencies

Physical Requirements

Travel up to 50% as required.

#LI-KJ1 #LI-Remote

Insulet Corporation (NASDAQ : PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.

We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!

Please read our Privacy Notice to learn how Insulet handles your personal information when you apply for a vacancy with us .